Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Files

589920.pdf (689.37 KB)

Document type

Article

Version

Published version

Publication date

2006-12-28

All rights reserved

Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/67129

Targeting the CYP2B1/cyclophosphamide suicide system to fibroblast growth factor receptors result in a potent antitumoral response in pancreatic cancer models

Journal Title

Authors

Director/Tutor

Journal ISSN

Volume Title

Related resource

http://dx.doi.org/10.1089/hum.2006.17.1187

Abstract

The CYP2B1/cyclophosphamide (CPA) suicide gene therapy approach has been shown to be highly promising in clinical trials for the treatment of pancreatic cancer. However, delivering the therapeutic gene to a sufficient number of tumor cells able to trigger a complete response remains a challenge. Target-specific delivery of adenovirus to fibroblast growth factor receptors (FGFRs) has been obtained in a variety of tumor models and has been shown to highly increase transduction efficiency. In the present paper we have tested the therapeutic outcome of retargeting the adenoviral vector, Ad-CYP2B1, to FGFRs, using an FGF2-Fab' conjugate, in pancreatic cancer models. First, we show a heterogeneous subcellular distribution of overexpressed FGFR-1 in pancreatic cancer cells. Higher transduction efficiency was observed in five of the six cell lines studied after FGF2-AdGFPLuc infection. Interestingly, an association between FGFR-1 membrane cell expression and viral entry was found. Moreover, tumors injected with FGF2-AdGFPLuc showed enhanced and persistent transgene expression. Importantly, we demonstrate the relevant enhanced cytotoxic effect of the FGF2-Ad-CYP2B]/CPA system in four of the six cell lines studied. Moreover, retargeting Ad-CYP2B1/CPA to FGFRs resulted in a potent antitumoral effect and in an increased survival rate, in two human pancreatic xenograft models. Thus, our results indicate that redirecting adenoviruses to FGFRs highly increases the potency of the suicide system CYP2B1/CPA. Consequently, it may constitute a promising approach to the treatment of patients with pancreatic tumors, in which a high proportion of FGF receptors precisely localize to the plasma membrane.

Subject

Càncer, Pàncrees

Subject (English)

Cancer, Pancreas

Citation

Collections

Articles publicats en revistes (Bioquímica i Biomedicina Molecular)

Citation

HUCH, Meritxell, et al. Targeting the CYP2B1/cyclophosphamide suicide system to fibroblast growth factor receptors result in a potent antitumoral response in pancreatic cancer models. Human Gene Therapy. 2006. Vol. 17, num. 1187-1200. ISSN 1043-0342. [consulted: 15 of August of 2026]. Available at: https://hdl.handle.net/2445/67129

Export metadata

JSON - METS

Share record